在美国，与具有滥用威慑技术的长效阿片类药物相关的社会经济效益。 - Suppr

Suppr

超能文献

Societal economic benefits associated with an extended-release opioid with abuse-deterrent technology in the United States.

作者信息

Kirson Noam Y, Shei Amie, White Alan G, Birnbaum Howard G, Ben-Joseph Rami, Rossiter Louis F, Michna Edward

机构信息

Analysis Group, Inc., Boston, Massachusetts, USA.

出版信息

Pain Med. 2014 Sep;15(9):1450-4. doi: 10.1111/pme.12489. Epub 2014 Jul 8.

DOI:10.1111/pme.12489

PMID:25041231

Abstract

摘要

相似文献

Societal economic benefits associated with an extended-release opioid with abuse-deterrent technology in the United States.在美国，与具有滥用威慑技术的长效阿片类药物相关的社会经济效益。

Pain Med. 2014 Sep;15(9):1450-4. doi: 10.1111/pme.12489. Epub 2014 Jul 8.

Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US.与具有滥用防御技术的延长释放阿片类药物相关的美国医疗成本节约。

J Med Econ. 2014 Apr;17(4):279-87. doi: 10.3111/13696998.2014.897628. Epub 2014 Mar 7.

Potential cost-shifting and hidden costs and risks in the economic analysis of opioid abuse-deterrent formulations.阿片类药物滥用威慑制剂经济分析中的潜在成本转移以及隐性成本和风险

Pain Med. 2014 Sep;15(9):1447-9. doi: 10.1111/pme.12500. Epub 2014 Jul 24.

Societal costs of prescription opioid abuse, dependence, and misuse in the United States.美国处方阿片类药物滥用、依赖和误用的社会成本。

Pain Med. 2011 Apr;12(4):657-67. doi: 10.1111/j.1526-4637.2011.01075.x. Epub 2011 Mar 10.

Decreasing use of controlled-release oxycodone: response to Morden et al, June 2008 Medical Care.控释羟考酮使用量的减少：对莫登等人于2008年6月发表在《医疗保健》上文章的回应

Med Care. 2008 Sep;46(9):1002. doi: 10.1097/MLR.0b013e3181858edc.

Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs.滥用可能性研究和现实世界非医疗使用中的积极主观测量：滥用威慑型阿片类药物对非医疗使用发生率及相关医疗保健成本的潜在影响。

J Opioid Manag. 2015 May-Jun;11(3):199-210. doi: 10.5055/jom.2015.0269.

Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.阿片类滥用防范制剂与美国的处方类阿片类药物滥用流行：从奥施康定中吸取的教训。

JAMA Psychiatry. 2015 May;72(5):424-30. doi: 10.1001/jamapsychiatry.2014.3043.

Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain.盐酸他喷他多缓释片治疗中重度慢性非癌痛的预算影响分析。

Clin Ther. 2013 May;35(5):659-72. doi: 10.1016/j.clinthera.2013.03.016. Epub 2013 Apr 13.

Economic burden of prescription opioid misuse and abuse.处方阿片类药物滥用和误用的经济负担。

J Manag Care Pharm. 2009 Sep;15(7):556-62. doi: 10.18553/jmcp.2009.15.7.556.

Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction.开发一种预算影响模型，以量化旨在防止滥用或便于提取的处方阿片类药物可能节省的成本。

Appl Health Econ Health Policy. 2009;7(1):61-70. doi: 10.1007/BF03256142.

引用本文的文献

Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.通过使用阿片类药物滥用阻止制剂来减轻静脉注射滥用：当前技术概述。

Pain Pract. 2019 Apr;19(4):443-454. doi: 10.1111/papr.12760. Epub 2019 Feb 28.

Next-generation sequencing of human opioid receptor genes based on a custom AmpliSeq™ library and ion torrent personal genome machine.基于定制的AmpliSeq™文库和离子激流个人基因组测序仪的人类阿片受体基因的新一代测序。

Clin Chim Acta. 2016 Dec 1;463:32-38. doi: 10.1016/j.cca.2016.10.009. Epub 2016 Oct 8.

Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid Users.一种滥用威慑（AD）长效（ER）吗啡候选产品（吗啡 - ADER 注塑片）与口服长效吗啡在非依赖型娱乐性阿片类药物使用者中的人体滥用潜力比较

Pain Med. 2017 May 1;18(5):898-907. doi: 10.1093/pm/pnw174.

Technology: Barriers to misuse.技术：防止滥用的障碍。

Nature. 2015 Jun 25;522(7557):S60-1. doi: 10.1038/522S60a.

The health insurance industry: perpetuating the opioid crisis through policies of cost-containment and profitability.医疗保险行业：通过成本控制和盈利政策使阿片类药物危机持续存在。

J Pain Res. 2015 Mar 18;8:153-8. doi: 10.2147/JPR.S83368. eCollection 2015.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验